DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)

Completed · Phase 4

Conditions studied: Anemia, Iron-Deficiency, Kidney Failure, Chronic, Hemodialysis

In brief

This study explores the safety and efficacy of intravenous iron therapy in anemic hemodialysis patients treated with epoetin alfa, who have higher serum ferritin levels, but low to normal transferrin saturation.

Key facts

Study ID

NCT00224081

Run by

Watson Pharmaceuticals

People needed

134

Starts

2004-09-01

Last updated by the study team

2015-12-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Chronic hemodialysis
• Elevated serum ferritin with low to normal transferrin saturation (TSAT)
• Moderate to severe anemia
• Receiving epoetin alfa treatment

You may not qualify if…

• Known sensitivity to Ferrlecit®
• Medical conditions that would confound the efficacy evaluation
• Recent blood transfusion

Where it is running

• Study site — Bakersfield, California, United States
• Study site — Glendale, California, United States
• Study site — Los Angeles, California, United States
• Study site — Santa Rosa, California, United States
• Study site — Torrance, California, United States
• Study site — Lauderdale Lakes, Florida, United States
• Study site — Tampa, Florida, United States
• Study site — Roswell, Georgia, United States
• Study site — Waycross, Georgia, United States
• Study site — Crestwood, Illinois, United States
• Study site — Wichita, Kansas, United States
• Study site — Shreveport, Louisiana, United States
• Study site — Boston, Massachusetts, United States
• Study site — Kalamazoo, Michigan, United States
• Study site — Royal Oak, Michigan, United States
• Study site — Columbia, Missouri, United States
• Study site — St Louis, Missouri, United States
• Study site — North Brunswick, New Jersey, United States
• Study site — Brooklyn, New York, United States
• Study site — Minneola, New York, United States
• Study site — New York, New York, United States
• Study site — Youngstown, Ohio, United States
• Study site — Philadelphia, Pennsylvania, United States
• Study site — Chattanooga, Tennessee, United States
• Study site — Knoxville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.